1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to treat musculat contrtation
Drug Name:
1/24. Zelsuvmi- Berdazimen- (Jan 2024)- to treat musculat contrtation
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2024
Sr.No- 1
Name of the Drug- ZELSUVMI
Active Ingredient - Berdazimen
Pharmacological Classification-
To trreat muscular contration
Date of Approval- 1/1/2024
(Ref- FDA approved List 2024)